Technology
Health
Pharmaceutical
DURECT
$1.029876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.2444 (33.64%) Today
+$0.05 (5.05%) As of 6:50 PM EDT after-hours
Why Robinhood?
You can buy or sell DURECT and other stocks, options, ETFs, and crypto commission-free!
About DRRX
DURECT Corporation Common Stock, also called DURECT, is a biopharmaceutical company, which engages in the research, development, and manufacturing of pharmaceutical products. The company products include alzet and lactel. Read More Its pipeline includes DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; and POSIMIR, which is an analgesic product intended to deliver bupivacaine to provide pain relief after surgery. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Employees
88
Headquarters
Cupertino, California
Founded
1998
Market Cap
117.93M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
407.77K
High Today
$1.05
Low Today
$0.8001
Open Price
$0.8001
Volume
13.15M
52 Week High
$1.66
52 Week Low
$0.46
Collections
Technology
Health
Pharmaceutical
Biopharmaceutical
Manufacturing
US
North America
Price Paid on Robinhood
14% Higher
Right Now
52 Week Low
$0.46
Average Price Paid
$0.8932
52 Week High
$2.25
DRRX Earnings
-$0.06
-$0.02
$0.01
$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 6, After Hours